AI & Data, Healthtech

Waiv

Next-generation precision tests

2026 – France

Waiv exists to catalyze precision medicine with clinical-grade, AI-powered tests that accelerate biomarker detection, outcome prediction, and treatment-response assessment across oncology. Built on over seven years of validated medical-AI innovation and one of Europe’s largest multi-institutional data networks, Waiv delivers precise, accurate, and fast analyses that support treatment decisions. Waiv collaborates with global pharmaceutical companies, research institutions, diagnostic organizations and healthcare systems to bring scalable precision medicine to patients worldwide.